Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

OKYO Pharma Limited Ordinary Shares (OKYO)

https://www.okyopharma.com

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/17/2022

Market Cap

32,907,013

Shares Outstanding

33,240,000

Weighted SO

33,236,050

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

-3.2990

Last Div

0.0000

Range

0.808-3.07

Chg

-0.0008

Avg Vol

43261

Mkt Cap

32907013

Exch

NASDAQ

Country

Phone

44 20 7495 2379

DCF Diff

0.8843

DCF

0.1058

Div Yield

0.0000

P/S

0.0000

EV Multiple

-8717.8262

P/FV

0.0000

Div Yield %

0.0000

P/E

-5.9308

PEG

0.0005

Payout

0.0000

Current Ratio

0.0000

Quick Ratio

0.0000

Cash Ratio

0.0000

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0016

ROA

0.0000

ROE

0.0037

ROCE

0.0000

NI/EBT

0.9984

EBT/EBIT

1.0128

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

0.0000

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.0897

FCF/Share

-0.0898

Cash/Share

0.0000

OCF/Sales

0.0000

FCF/OCF

1.0007

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-1408.0666

Div&CapEx Cov

-1408.0666

P/BV

0.0000

P/B

0.0000

P/S

0.0000

P/E

-5.9308

P/FCF

-16028.6667

P/OCF

-11.0373

P/CF

-11.0373

PEG

0.0005

P/S

0.0000

EV Multiple

-8717.8262

P/FV

0.0000

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 05, 09:30 OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024 OKYO

Revenue Product Segmentation

Year	Purchases	Sales	Total Bought	Total Sold

Transaction Date	Name	Type Of Owner	Price	Securities Owned	Securities Transacted	Security Name	Transaction Type

Less Than 3 Months

0.00 Shares Bought (0 %)

0.00 Shares Sold (0%)

3 - 6 Months

0.00 Shares Bought (0 %)

0.00 Shares Sold (0%)

6 - 9 Months

0.00 Shares Bought (0 %)

0.00 Shares Sold (0%)

9 - 12 Months

0.00 Shares Bought (0 %)

0.00 Shares Sold (0 %)

Investor Name	Investment Discretion	Type of Security	Shares Owned	Avg Price Paid	Market Value	Change In Market Value	Change In Market Value (%)	Ownership	Weight

Date	Investors Holding	Closed Positions	Increased Positions	Reduced Positions	New Positions	Total Invested	Put/Call Ratio	Total Calls	Total Puts

Owner	Shares Owned

	2023	2023	1970
Revenue	0.00	0.00
Cost Of Revenue	1.57K	▼ 0.00
Gross Profit	-1.57K	▲ 0.00
Gross Profit Ratio	0.00	0.00	▼
Research And Development Expenses	1.49K	▼ 0.00
General And Administrative Expenses	0.00	0.00
Selling And Marketing Expenses	0.00	0.00
Selling General And Administrative Expenses	0.00	0.00
Other Expenses	0.00	0.00
Operating Expenses	1.49K	▼ 0.00
Cost And Expenses	3.06K	▼ 0.00
Interest Income	0.00	0.00
Interest Expense	0.00	0.00
Depreciation And Amortization	1.00	▼ 0.00
Ebitda	-3.06K	▲ 0.00
Ebitda Ratio	0.00	0.00	▼
Operating Income	-3.06K	▲ 0.00
Operating Income Ratio	0.00	0.00	▼
Total Other Income Expenses Net	-39.00	▲ 0.00
Income Before Tax	-3.10K	▲ 0.00
Income Before Tax Ratio	0.00	0.00	▼
Income Tax Expense	5.00	▼ 0.00
Net Income	-3.10K	▲ 0.00
Net Income Ratio	0.00	0.00	▼
Eps	-0.14	▲ 0.00	▼
Eps Diluted	-0.14	▲ 0.00	▼
Weighted Average Shs Out	22.87K	▼ 0.00
Weighted Average Shs Out Dil	22.87K	▼ 0.00